Larvol Delta - Alzamend-Neuro-Submits-IND-Application-for-a-Phase-IIA-Clinical-Trial-in-PostTraumatic-Stress-Disorder-Patients-of-NextGeneration-Lithium-Therapeutic-Drug-Candidate-AL001

LISPRO (lithium/proline/salicylate) - Alzamend Neuro

https://www.businesswire.com/news/home/20231113906125/en/Alzamend-Neuro-Submits-IND-Application-for-a-Phase-IIA-Clinical-Trial-in-Post-Traumatic-Stress-Disorder-Patients-of-Next%E2%80%91Generation-Lithium-Therapeutic-Drug-Candidate-AL001

Nov 13, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next